L-α-glycerophosphorylcholine Purification via Amino HPLC and ELSD
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying L-α-glycerophosphorylcholine (GPC) face challenges due to the toxicity of synthetic precursors and the limitations of existing analytical techniques, such as Thin Layer Chromatography and HPLC, which struggle with sensitivity and separation of impurities like β-GPC and cyclic species, leading to concerns about product purity and therapeutic efficacy.
Innovation Solution
The use of an amino HPLC column with an Evaporative Light Scattering Detector (ELSD) for precise detection and purification of GPC, combined with crystallization from dimethyl sulfoxide (DMSO) or its mixtures, allows for high-purity GPC production with reduced impurities like β-GPC and cyclic species, overcoming previous analytical limitations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If Thin Layer Chromatography is used for purity verification, then versatility in evaluating all components is improved, but measurement precision for quantitative determination of impurities deteriorates
Solution Approach 1:
The patent introduces HPLC with amino stationary phase as an intermediary analytical technique that bridges the gap between the versatility of TLC and the precision requirements. The amino phase acts as a mediator that provides both broad component evaluation capability and precise quantitative determination of impurities like β-GPC and cyclic species through improved chromatographic separation.
2Difficulty of detecting and measuring
If conventional HPLC is used for GPC analysis, then detection capability is improved, but measurement precision deteriorates due to peak enlargement and asymmetry
Solution Approach 1:
The patent applies parameter changes by modifying the HPLC stationary phase to amino phase, which fundamentally alters the interaction parameters between GPC and the column. This change in stationary phase chemistry resolves the peak enlargement and asymmetry issues, enabling precise measurement while maintaining detection capability.
Solution Approach 2:
The patent replaces the conventional detection approach with Evaporative Light Scattering Detection (ELSD), substituting the traditional UV detection mechanism. This replacement eliminates detector-related peak distortion and provides superior measurement precision for GPC and its impurities.
3Productivity
If synthetic precursors are used for GPC production, then productivity is improved, but object-affected harmful factors worsen due to toxicity concerns
Solution Approach 1:
The patent extracts and removes toxic impurities and residual precursors from the GPC product through the improved purification process. By combining HPLC separation with ELSD detection, the method selectively extracts harmful substances while retaining the active ingredient, thus maintaining productivity while eliminating toxicity concerns.
Solution Approach 2:
The patent converts the challenge of toxic impurity removal into a benefit by using the specific interaction properties of the amino stationary phase. The harmful impurities are selectively retained or eluted at different times, transforming the purification challenge into an opportunity for enhanced product safety while maintaining efficient production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves GPC purity greater than 99.5% with minimal β-GPC and cyclic impurities, enhancing the therapeutic profile and safety of GPC preparations, and provides a more sensitive and selective method for impurity detection.
Implementation Method 1
the elution of L-α-glycerophosphorylcholine through an HPLC column having an amino stationary phase
Implementation Method 2
subsequent detection of L-α-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type
Implementation Method 3
subsequent detection of L-α-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type
Implementation Method 4
L-α-glycerophosphorylcholine is crystallized from DMSO or from a mixture of DMSO with at least another solvent
Data Source
AI summary
A process for the purification of L-α-glycerophosphorylcholine is described, wherein L-α-glycerophosphorylcholine is crystallized from DMSO or from a mixture of DMSO with at least another solvent, preferably selected from water, alcohol, halogenated solvents, ethers, esters and/or amides. Such a process allows to obtain L-α-glycerophosphorylcholine having a purity greater than 99.5%, preferably greater than 99.7%, even more preferably greater than or equal to 99.9%. A method for determining the purity of L-α-glycerophosphorylcholine is also described, comprising the elution of L-α-glycerophosphorylcholine through an HPLC column having an amino stationary phase, and subsequent detection of L-α-glycerophosphorylcholine itself, and any impurity thereof, by means of an Evaporative Light Scattering Detector type.